MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
for Recurrent Acute Myeloid Leukemia
1 location in Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT07025564·Phase 1·Recruiting·Listed Jun 2025
Paid Clinical Trials in Duarte, CA
As of September 2026, 546 paid clinical trials are recruiting in Duarte, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
508 clinical trials
Get a weekly email when new trials open in Duarte, CA.
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
for Relapsed Acute Myeloid Leukemia (AML)
Sites in Duarte +4 more locations
Sponsor: Auron Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06846606·Phase 1·Recruiting·Listed Feb 2025
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for Endometrial Cancer
Drug: Rilvegostomig
Sites in Duarte, Irvine +45 more locations
Sponsor: AstraZeneca
Sex: Female·Age: 18+
Code: NCT06989112·Phase 3·Recruiting·Listed May 2025
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
for Lymphoma
Sites in Duarte +6 more locations
Sponsor: AstraZeneca
Sex: All·Age: 12+
Code: NCT06137144·Phase 1, Phase 2·Recruiting·Listed Nov 2023
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for HER2-positive Gastric Cancer
Drug: Rilvegostomig
Sites in Duarte, Upland +44 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06764875·Phase 3·Recruiting·Listed Jan 2025
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
for B-cell Non-Hodgkin Lymphoma
Sites in Duarte +15 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06526793·Phase 2·Recruiting·Listed Jul 2024
M-2018-334 in Hematological Malignancies
for Hematological Malignancies
1 location in Duarte
Sponsor: Miltenyi Biomedicine GmbH
Sex: All·Age: 18 - 75
Code: NCT06225050·Recruiting·Listed Jan 2024
Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
for Currently Only Enrolling Glioblastoma Patients at First Recurrence
Sites in Duarte, Stanford +1 more location
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT05139056·Phase 1·Recruiting·Listed Dec 2021
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
for Metastatic Malignant Solid Neoplasm
Sites in Duarte, South Pasadena +16 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05372614·Phase 1·Recruiting·Listed May 2022
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
for Non-small Cell Lung Cancer
Sites in Duarte, Los Angeles +17 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT05877599·Phase 1·Recruiting·Listed May 2023
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
for Non-small Cell Lung Cancer
Sites in Duarte, Los Angeles +16 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06218914·Phase 1·Recruiting·Listed Jan 2024
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
for Ovarian Cancer
Sites in Duarte, Irvine +8 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 130
Code: NCT05797168·Phase 1, Phase 2·Recruiting·Listed Apr 2023
To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
for Locally Advanced or Metastatic HER2-Expressing Cancers
1 location in Duarte
Sponsor: Vir Biotechnology, Inc.
Sex: All·Age: 18+
Code: NCT05356741·Phase 1, Phase 2·Recruiting·Listed May 2022
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
for Multiple Myeloma
Sites in Duarte, Irvine +6 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06106945·Phase 1, Phase 2·Recruiting·Listed Oct 2023
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
for B-cell Acute Lymphoblastic Leukemia (B-ALL)
Sites in Duarte, Los Angeles +8 more locations
Sponsor: AstraZeneca
Sex: All·Age: 12+
Code: NCT06137118·Phase 1, Phase 2·Recruiting·Listed Nov 2023
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for Metastatic Clear Cell Renal Cell Carcinoma
Drug: Cabozantinib
Sites in Duarte, Los Angeles +44 more locations
Sponsor: Arcus Biosciences, Inc.
Sex: All·Age: 18+
Code: NCT07011719·Phase 3·Recruiting·Listed Jun 2025
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
for Distal Bile Duct Adenocarcinoma
1 location in Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT05285358·Phase 1·Recruiting·Listed Mar 2022
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
for Clear Cell Renal Cell Carcinoma
Sites in Duarte, Sacramento +18 more locations
Sponsor: Xencor, Inc.
Sex: All·Age: 18+
Code: NCT05433142·Phase 1·Recruiting·Listed Jun 2022
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for Solid Tumor
Drug: INBRX-106
Sites in Duarte, Glendale +11 more locations
Sponsor: Inhibrx Biosciences, Inc
Sex: All·Age: 18+
Code: NCT04198766·Phase 1, Phase 2·Recruiting·Listed Dec 2019
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
for B-cell Acute Lymphoblastic Leukemia (B-ALL)
Sites in Duarte +4 more locations
Sponsor: AstraZeneca
Sex: All·Age: 12+
Code: NCT07109219·Phase 1, Phase 2·Recruiting·Listed Aug 2025
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for Recurrent Acute Myeloid Leukemia
1 location in Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT06763341·Phase 1·Recruiting·Listed Jan 2025
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
for Multiple Myeloma
Sites in Duarte +9 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07073547·Phase 1·Recruiting·Listed Jul 2025
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
for Myelodysplastic Syndromes
Sites in Duarte, Irvine +4 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT06847867·Phase 2·Recruiting·Listed Feb 2025
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for Solid Tumor
Sites in Duarte, La Jolla +15 more locations
Sponsor: Biohaven Therapeutics Ltd.
Sex: All·Age: 18+
Code: NCT06384807·Phase 1, Phase 2·Recruiting·Listed Apr 2024
Study of AZD0754 in Participants With Metastatic Prostate Cancer
for Metastatic Prostate Cancer
Sites in Duarte +12 more locations
Sponsor: AstraZeneca
Sex: Male·Age: 18 - 130
Code: NCT06267729·Phase 1, Phase 2·Recruiting·Listed Feb 2024
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
for Breast Carcinoma
1 location in Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT06130826·Phase 1·Recruiting·Listed Nov 2023